Work

Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.7_suppl.575

Authors: Amishi Yogesh Shah, Ritesh Kotecha, Emily Lemke, Anuradha Chandramohan, Joshua Chaim, Pavlos Msaouel, Lianchun Xiao, Jianjun Gao, Matthew T Campbell, Amado J. Zurita, Jennifer Wang, Paul Gettys Corn, Eric Jonasch, Robert J. Motzer, Padmanee Sharma, Martin Henner Voss, Nizar M. Tannir

Institutions: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920936787

Cites:

Cited by: 13

Related to: 10